Chongqing Sdem Biotechnology

Chongqing Sdem Biotechnology is a clinical-stage biopharmaceutical company based in Chongqing, China, specializing in the discovery and development of innovative small molecule therapeutics. The company focuses on high-impact therapeutic areas, including oncology and metabolic disorders, to address critical unmet medical needs. Its lead candidate, SDM-001, is currently undergoing Phase 1 clinical trials for the treatment of advanced solid tumors, demonstrating the company's transition into a clinical-stage entity. Sdem Biotechnology leverages its proprietary research platform and internal expertise to advance a pipeline of novel drug candidates toward commercialization.